NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-9.25	Insider Own	0.20%	Shs Outstand	73.03M	Perf Week	-12.67%
Market Cap	9.54B	Forward P/E	4.37	EPS next Y	32.07	Insider Trans	-55.90%	Shs Float	62.53M	Perf Month	-38.35%
Income	-615.10M	PEG	-	EPS next Q	-3.76	Inst Own	54.30%	Short Float	7.12%	Perf Quarter	-46.65%
Sales	919.50M	P/S	10.38	EPS this Y	-32.00%	Inst Trans	2.71%	Short Ratio	1.20	Perf Half Y	54.24%
Book/sh	14.23	P/B	9.85	EPS next Y	54.00%	ROA	-40.60%	Target Price	-	Perf Year	221.25%
Cash/sh	29.34	P/C	4.78	EPS next 5Y	0.00%	ROE	-125.70%	52W Range	40.50 - 331.68	Perf YTD	25.69%
Dividend	-	P/FCF	16.58	EPS past 5Y	9.50%	ROI	-38.00%	52W High	-55.73%	Beta	1.66
Dividend %	-	Quick Ratio	1.90	Sales past 5Y	67.30%	Gross Margin	-	52W Low	262.57%	ATR	20.33
Employees	791	Current Ratio	1.90	Sales Q/Q	3072.20%	Oper. Margin	-65.50%	RSI (14)	39.67	Volatility	14.13% 12.10%
Optionable	Yes	Debt/Eq	0.44	EPS Q/Q	-423.70%	Profit Margin	-66.90%	Rel Volume	0.90	Prev Close	140.16
Shortable	Yes	LT Debt/Eq	0.33	Earnings	May 10 AMC	Payout	-	Avg Volume	3.71M	Price	146.84
Recom	2.00	SMA20	-21.67%	SMA50	-23.43%	SMA200	-3.06%	Volume	2,060,168	Change	4.77%

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

May-18-21 06:00AM	Here's Why This Top Stock Is a Buy on the Dip Motley Fool
05:21AM	Vaccine manufacturer Oxford Biomedica doubles sales forecasts as AstraZeneca ups orders Yahoo Finance UK
May-17-21 07:43AM	Buy-the-Dip Candidates: Jim Cramer Still Likes Disney Stock TheStreet.com +6.43%
06:06AM	5 Risky Stocks With 138% to 216% Upside, According to Wall Street Motley Fool
May-16-21 11:09PM	SK bioscience's COVID-19 vaccine plant in South Korea gets European nod Reuters
May-15-21 06:06AM	4 Large-Cap Stocks That Turned $200,000 Into $1 Million (or More) in 1 Year Motley Fool
06:02AM	Why Novavax's Pending COVID Vaccine Deal With the EU Raised Concerns Motley Fool
May-14-21 05:27PM	Novavaxs Long-Term Outlook Remains Intact, Says Analyst TipRanks +8.83%
04:06PM	Doctor: 'I will be wearing masks indoors for the foreseeable future Yahoo Finance Video
03:29PM	COVID-19 vaccinations and mitigation turned the corner on school reopening: AFT President Yahoo Finance Video
01:40PM	People choosing to ditch their masks will be a gradual process: Doctor Yahoo Finance Video
12:48PM	The Dip In Novavax Is The Perfect Buying Opportunity InvestorPlace
May-13-21 02:27PM	CDC approves those fully vaccinated to largely ditch masks indoors Yahoo Finance Video -5.34%
02:16PM	CDC recommends Pfizer vaccine for children 12 to 15 years-old Yahoo Finance Video
06:00AM	This Is Novavax's Biggest Weakness Right Now -- and Here's How the Company May Overcome It Motley Fool
May-12-21 02:14PM	Novavax Reports Positive Data From Animal Trial of Its COVID-19/Flu Combo Shot Motley Fool -7.50%
02:14PM	'The biggest risk for Americans right now regarding COVID-19 is whats happening across the world': Doctor Yahoo Finance Video
10:50AM	Novavaxs Manufacturing Issues May Be Its Top Vaccine Struggle, Analyst Says Barrons.com
09:24AM	Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints Investor's Business Daily
05:55AM	Why Novavax Could Beat Moderna in Europe After Pfizer's Huge EU Vaccine Deal Motley Fool
May-11-21 05:51PM	Why Novavax Stock Sank Again on Tuesday Motley Fool -13.91%
02:09PM	COVID-19 booster shot is likely and its okay: Doctor Yahoo Finance Video
12:22PM	Novavax's (NVAX) Q1 Loss Widens, Revenues Beat, Shares Down Zacks
11:40AM	Is Novavax Stock A Sell After Announcing Another Covid Vaccine Delay? Investor's Business Daily
10:30AM	Global cases and deaths from COVID-19 are plateauing but Indias crisis continues to deepen MarketWatch
09:10AM	Novavax Down Second Straight Day On Concerns About Delays Investing.com
08:15AM	Novavax Shares Tumble as Vaccine Delays Mount Barrons.com
07:31AM	Devon Energy, Bilibili, Novavax, Roblox and Wynn Resorts highlighted as Zacks Bull and Bear of the Day Zacks
05:52AM	Here's the Only Thing in Novavax's Q1 Update That Investors Cared About Motley Fool
05:13AM	Novavax Swings to a 1Q Loss; Shares Plunge 9% SmarterAnalyst
04:11AM	Premarket Movers Tuesday - Tesla, Palantir, Novavax, Virgin Galactic TheStreet.com
May-10-21 07:37PM	Novavax Plunges Amid Dismay Over Timeline for Covid-19 Shot Bloomberg -8.81%
06:26PM	Why Novavax Tanked Monday Motley Fool
05:55PM	Novavax (NVAX) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:50PM	Novavax (NVAX) Dips More Than Broader Markets: What You Should Know Zacks
05:32PM	WHO classifies triple-mutant Covid variant from India as global health risk Yahoo Finance Video
04:30PM	Novavax Q1 revenue beats estimates Yahoo Finance Video
04:17PM	Novavax delays timelines for COVID-19 vaccine regulatory filings, production Reuters
04:02PM	Novavax Reports First Quarter 2021 Financial Results and Operational Highlights PR Newswire
02:21PM	Novavax Drops on Delay in Vaccine Clearance Request TheStreet.com
01:53PM	COVID-19 is not at the point yet where we can have mass gatherings: Doctor Yahoo Finance Video
11:43AM	Why Shares Of Novavax Are Down By 8% Today? FX Empire
11:10AM	Novavaxs Covid-19 Vaccine Could Still Be Months Off Barrons.com
09:55AM	Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate PR Newswire
09:12AM	Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate CNW Group
08:35AM	Novavax Slips on Reported Delay to Seek FDA Vaccine Clearance TheStreet.com
07:31AM	Novavax Drops on Reports of Vaccine Delay Investing.com
May-08-21 08:00AM	These four COVID-19 vaccines could soon join the pandemic fight Fortune
May-07-21 04:30PM	Vaccine Stocks Take Wild Ride Amid Political Clash, Earnings Bloomberg
02:04PM	We are not out of the woods with this pandemic: Doctor Yahoo Finance Video
01:54PM	Pfizer begins process of seeking full U.S. vaccine approval: RPT Yahoo Finance Video
09:17AM	UPDATE 1-Novavax expects COVID-19 vaccine supply in Japan well into 2022 Reuters
06:15AM	Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market? Motley Fool
May-06-21 06:37PM	Should Novavax Be Worried About Losing IP Rights? Motley Fool
01:54PM	U.S. backing waiver of patent protection for vaccines is a complex issue: Doctor Yahoo Finance Video
11:37AM	Elizabeth Warren responds to Biden's backing of COVID-19 vaccine patent waivers: 'I'm delighted' Yahoo Finance
10:56AM	Moderna and Other Covid-19 Vaccine Stocks Are Sliding. The Reaction Might Be Overblown. Barrons.com
09:53AM	Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility PR Newswire
09:45AM	UPDATE 2-Novavax to start shipping COVID-19 vaccines to COVAX program in third quarter Reuters
May-05-21 06:45PM	UPDATE 1-Novavax vaccine shows 51% efficacy against South African variant, study finds Reuters
05:52PM	Moderna Stock Dives As Biden Considers Waiving Covid Vaccine Patents Investor's Business Daily
05:22PM	Moderna releases new information on booster shots Yahoo Finance Video
05:03PM	New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant PR Newswire
05:00PM	Novavax vaccine shows 43% efficacy against South African variant, study finds Reuters
02:06PM	Former Acting CDC Director on why it's 'really important' to pay attention to COVID-19 variants Yahoo Finance Video
11:14AM	Investing in the Covid-19 vaccine companies? Heres the great divide in the group MarketWatch
07:08AM	Should Pfizer and Moderna Be Worried About This New COVID Vaccine Study? Motley Fool
06:00AM	Should You Buy Novavax Before Its Earnings Report? Motley Fool
May-04-21 04:00PM	Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus Zacks -7.41%
03:18PM	How businesses are tracking their employee's vaccination status and well-being amid COVID-19 recovery Yahoo Finance Video
02:44PM	Biden aims to have 70% of U.S. adults receive first vaccine shot by July 4th Yahoo Finance Video
02:02PM	Returning to normal doesnt have to be the goal amid COVID-19 recovery: Doctor Yahoo Finance Video
09:55AM	Why Shares of Novavax Rose 31% Last Month Motley Fool
May-03-21 03:29PM	These 2 Once-Hot Stocks Sent the Nasdaq Lower Monday Motley Fool -17.65%
02:52PM	Europe To Get Novavax COVID-19 Vaccines But Not Before End Of 2021: Reuters Benzinga
02:32PM	A one size fits all policy for reopening travel is very concerning: Doctor Yahoo Finance Video
12:48PM	Why Novavax Stock Is Sinking Today Motley Fool
09:35AM	Novavax begins testing its COVID-19 vaccine candidate in teens MarketWatch
08:51AM	Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine PR Newswire
Apr-30-21 05:45PM	Novavax (NVAX) Stock Moves -0.25%: What You Should Know Zacks
02:44PM	West Virginia Governor on offering incentives after state hit a wall in vaccinations Yahoo Finance Video
01:37PM	California has lowest COVID-19 case rate in the U.S.: RPT Yahoo Finance Video
11:53AM	Novavax Secures Additional $147M From Warp Speed Program For COVID-19 Vaccine Benzinga
06:25AM	2 Top Biotech Stocks to Buy Right Now Motley Fool
Apr-29-21 04:49PM	Dr. Krutika Kuppalli explains why COVID-19 cases could get worse in India before improving Yahoo Finance Video
04:07PM	Novavax Vaccine Results Will Put 1,190% Stock Surge to Test Bloomberg
01:51PM	NYC reopening timeline is a disastrous issue: Doctor Yahoo Finance Video
08:01AM	Novavax Vaccine to Get U.S. Approval? ETFs to Benefit Zacks
07:15AM	Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization? Investor's Business Daily
Apr-28-21 01:32PM	Its good to lift COVID-19 restrictions right now: UAB Epidemiologist Yahoo Finance Video -5.20%
12:24PM	Why Novavax Stock Is Tumbling Today Motley Fool
11:52AM	Fauci says world shares blame for Indias COVID crisis by failing to coordinate global pandemic response MarketWatch
09:15AM	Novavax (NVAX) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-27-21 10:13PM	UPDATE 1-Top U.S. trade negotiator discussed vaccine ramp-up with Novavax exec Reuters +16.33%
07:45PM	Top U.S. trade negotiator discusses vaccine ramp-up with Novavax exec -USTR Reuters
04:50PM	Novavax Sparks Again As Biden Hints Covid Vaccine Is Nearing Authorization Investor's Business Daily
04:48PM	Novavax shares jump after Biden says focusing on its vaccine Reuters
04:40PM	Why Novavax Stock Popped Today Motley Fool
04:37PM	Novavax shares jump after Biden says focusing on its vaccine Reuters
02:49PM	Novavax's stock jumps after Biden mentions its COVID-19 vaccine candidate MarketWatch

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trizzino John	EVP, CCO, CBO & Interim CFO	May 07	Sale	176.63	190	33,559	287	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Option Exercise	14.73	3,406	50,160	3,309	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Sale	185.46	3,022	560,471	287	May 07 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Option Exercise	14.82	2,895	42,892	3,170	May 04 06:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Sale	239.83	2,895	694,317	275	May 04 06:03 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 07	Sale	178.03	191	34,004	287	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Option Exercise	34.01	3,404	115,771	3,308	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Sale	190.10	3,021	574,292	287	Apr 07 05:09 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Option Exercise	14.82	2,894	42,886	3,169	Mar 30 06:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Sale	186.80	2,894	540,609	275	Mar 30 06:10 PM
YOUNG JAMES F	Director	Mar 25	Option Exercise	8.96	47,500	425,438	57,500	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Option Exercise	46.00	10,000	460,000	20,000	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Sale	228.22	10,000	2,282,231	10,000	Mar 25 06:41 PM
MCMANUS MICHAEL A JR	Director	Mar 19	Sale	220.78	4,000	883,110	5,951	Mar 23 05:33 PM
Glenn Gregory M	President, R&D	Mar 17	Sale	218.86	2,423	530,304	2,811	Mar 17 06:35 PM
Glenn Gregory M	President, R&D	Mar 15	Option Exercise	109.95	10,531	1,157,843	8,523	Mar 17 06:35 PM
EVANS GARY C	Director	Mar 15	Option Exercise	19.52	24,500	478,330	40,599	Mar 17 06:36 PM
EVANS GARY C	Director	Mar 15	Sale	211.21	24,500	5,174,536	16,099	Mar 17 06:36 PM
Glenn Gregory M	President, R&D	Mar 15	Sale	198.60	5,712	1,134,400	2,811	Mar 17 06:35 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 09	Sale	168.09	190	31,937	287	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Option Exercise	14.73	3,404	50,148	3,308	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Sale	163.46	3,021	493,824	287	Mar 09 07:38 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Option Exercise	14.82	2,895	42,892	3,170	Mar 02 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Sale	225.48	2,895	652,759	275	Mar 02 05:37 PM
Glenn Gregory M	President, R&D	Feb 18	Sale	269.57	2,434	656,134	2,811	Feb 18 06:59 PM
Glenn Gregory M	President, R&D	Feb 16	Option Exercise	13.16	10,531	138,577	8,523	Feb 18 06:55 PM
Glenn Gregory M	President, R&D	Feb 16	Sale	282.71	5,712	1,614,812	2,811	Feb 18 06:55 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 09	Sale	324.50	194	62,953	287	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Option Exercise	14.73	3,406	50,160	3,309	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Sale	290.46	3,022	877,766	287	Feb 09 07:40 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Option Exercise	18.15	15,022	272,724	15,297	Feb 03 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Sale	241.50	15,022	3,627,789	275	Feb 03 05:37 PM
Trizzino John	EVP, CMO and CBO	Jan 07	Sale	124.17	506	62,830	287	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Option Exercise	18.63	13,756	256,243	17,694	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Sale	112.00	17,407	1,949,522	287	Jan 07 07:08 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	51.27	11,000	564,000	11,000	Jan 05 05:38 PM
DOUGLAS RICHARD	Director	Dec 31	Option Exercise	50.00	1,000	50,000	28,500	Jan 05 05:42 PM
YOUNG JAMES F	Director	Dec 31	Sale	113.09	11,000	1,244,014	0	Jan 05 05:38 PM
Erck Stanley C	President and CEO	Nov 16	Option Exercise	37.14	52,317	1,942,801	72,811	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Nov 16	Sale	90.65	52,316	4,742,667	20,495	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Oct 01	Sale	108.56	2	217	20,494	Oct 01 05:39 PM
Trizzino John	EVP, CBO and CFO	Sep 30	Sale	110.22	2,250	248,002	5,087	Oct 01 05:40 PM
Erck Stanley C	President and CEO	Sep 30	Sale	110.23	12,231	1,348,200	20,496	Oct 01 05:39 PM
Erck Stanley C	President and CEO	Sep 29	Sale	107.80	4,112	443,267	32,727	Sep 30 09:27 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 29	Sale	107.31	18,029	1,934,667	275	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 29	Sale	107.02	19,949	2,134,844	1,561	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 29	Sale	107.29	18,321	1,965,630	7,337	Sep 30 09:28 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Option Exercise	5.95	29,600	176,120	53,008	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 28	Option Exercise	5.95	50,000	297,500	74,606	Sep 30 09:27 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Option Exercise	5.95	24,750	147,262	43,054	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Option Exercise	5.95	25,000	148,750	46,510	Sep 30 09:29 PM
Erck Stanley C	President and CEO	Sep 28	Sale	110.30	25,000	2,757,456	36,839	Sep 30 09:27 PM
Glenn Gregory M	President, R&D	Sep 28	Sale	110.30	25,000	2,757,456	21,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Sale	110.30	25,000	2,757,456	25,658	Sep 30 09:28 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Sale	110.30	24,750	2,729,879	18,304	Sep 30 09:30 PM
EVANS GARY C	Director	Aug 18	Option Exercise	31.02	10,500	325,700	332,479	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Aug 18	Option Exercise	33.56	55,921	1,876,525	57,760	Aug 20 06:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Option Exercise	53.82	46,242	2,488,613	46,517	Aug 20 06:20 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Option Exercise	27.60	8,000	220,800	17,951	Aug 20 06:22 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Option Exercise	50.95	42,788	2,179,986	47,875	Aug 20 06:25 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Sale	148.78	42,788	6,366,182	5,087	Aug 20 06:25 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Sale	146.00	8,000	1,168,000	9,951	Aug 20 06:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Sale	144.33	46,242	6,673,982	275	Aug 20 06:20 PM
Glenn Gregory M	President, R&D	Aug 18	Sale	145.20	55,921	8,119,860	1,839	Aug 20 06:14 PM
EVANS GARY C	Director	Aug 18	Sale	150.44	10,500	1,579,620	321,979	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Jun 18	Option Exercise	42.20	16,749	706,808	18,588	Jun 22 05:29 PM
Glenn Gregory M	President, R&D	Jun 18	Sale	59.53	16,749	997,103	1,839	Jun 22 05:29 PM
YOUNG JAMES F	Director	Jun 03	Buy	48.83	1,500	73,245	1,500	Jun 05 05:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience